Regulatory role and molecular mechanism of METTL14 in vascular endothelial cell injury in preeclampsia
Biomolecules and Biomedicine · 2024
DOI: 10.17305/bb.2024.10963 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules and Biomedicine, 2024. Verfasst von Huafang Wei und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecology and Obstetrics, General Hospital of the Central Theater Command of the Chinese People's Liberation Army, Wuhan, China. Hauptthemen laut MEDLINE: Methyltransferases, Pre-Eclampsia. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Preeclampsia (PE) is a pregnancy-related disease characterized by vascular endothelial cell injury. This study aimed to investigate the role of methyltransferase-like protein 14 (METTL14) in vascular endothelial cell injury in PE. A PE cell model was established by treating human umbilical vein endothelial cells (HUVECs) with tumor necrosis factor-alpha (TNF-α) in vitro. METTL14 and forkhead box protein 1 (FOXP1) were silenced, and miR-34a-5p was overexpressed in HUVECs to evaluate their effects. HUVEC viability, apoptosis, and levels of intercellular adhesion molecule 1, vascular cell adhesion molecule 1, and endothelin-1 were measured. The N6-methyladenosine (m6A) modification of pri-miR-34a-5p was quantified. The interactions between miR-34a-5p, DiGeorge syndrome critical region 8, and m6A enrichment in miR-34a-5p were analyzed. The relationship between miR-34a-5p and FOXP1 was also verified. The results showed the expressions of METTL14, FOXP1, and miR-34a-5p. METTL14 expression was elevated in the TNF-α-induced HUVEC injury model. Silencing METTL14 improved HUVEC viability, inhibited apoptosis, and reduced endothelial inflammation. METTL14 promoted miR-34a-5p expression through m6A modification. Overexpression of miR-34a-5p or silencing FOXP1 reversed the protective effects of METTL14 silencing on cell injury in the PE model. In conclusion, METTL14 mediated m6A modification to promote miR-34a-5p expression, leading to FOXP1 inhibition, which aggravated endothelial cell damage in the PE cell model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gynaecology and Obstetrics, General Hospital of the Central Theater Command of the Chinese People's Liberation Army, Wuhan, China.
- Supervision Office, Changsha Health Vocational College, Changsha, China.
Zitieren
APA
Wei, H., Liang, L., Song, C., Tong, M., & Xu, X. (2024). Regulatory role and molecular mechanism of METTL14 in vascular endothelial cell injury in preeclampsia. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2024.10963
Vancouver
Wei H, Liang L, Song C, Tong M, Xu X. Regulatory role and molecular mechanism of METTL14 in vascular endothelial cell injury in preeclampsia. Biomolecules and Biomedicine. 2024. doi:10.17305/bb.2024.10963
BibTeX
@article{Wei2024,
author = {Wei, Huafang and Liang, Lin and Song, Chengwen and Tong, Ming and Xu, Xiang},
title = {Regulatory role and molecular mechanism of METTL14 in vascular endothelial cell injury in preeclampsia},
journal = {Biomolecules and Biomedicine},
year = {2024},
doi = {10.17305/bb.2024.10963}
}
EUVIMED